Nanoco: Reaching two key milestones in H222

Nanoco’s post-close trading update notes that the FY22 performance was broadly in line with management’s expectations. We therefore leave our estimates unchanged except for adjustments relating to the broker option element of the fund-raising programme in June, which was very significantly oversubscribed, and charges linked to the loan notes issued in July 2021.

FY22 trading broadly in line with expectations

Management notes that FY22 revenues will be £2.4m, in line with our estimates, and that adjusted LBITDA will be slightly ahead of their expectations because of successful cost management.

Nanoco Group PLC (LON:NANO) leads the world in the research, development and large-scale manufacture of heavy metal-free nanomaterials for use in displays, lighting, vertical farming, solar energy and bio-imaging.

Click to view all articles for the EPIC:
Or click to view the full company profile:
Facebook
X
LinkedIn
Nanoco Group PLC

More articles like this

Nanoco Group PLC

Quantum Dots could revolutionise your portfolio

Unlock the potential of quantum dots – microscopic particles revolutionizing industries with vibrant displays, efficient sensors, and advanced medical tools. Experience the economic opportunities with Nanoco Group PLC.

Nanoco Group PLC

QDs: Harnessing Quantum Confinement

Explore the groundbreaking research on colloidal quantum dots and their ability to control photochemical reactions through quantum coherence.

Nanoco Group PLC

The promise of Quantum Dots

Quantum dots (QDs) represent a significant advancement in nanotechnology, finding applications across diverse fields. In bioimaging, their small size enables them to access almost any part of the body, making them ideal for tasks like medical